Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
322 participants
OBSERVATIONAL
2018-03-14
2024-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children
NCT04207892
Pediatric Femur Research Project
NCT00943332
Evaluation of the AO Pediatric Classification for Long Bones Fractures Like a Guide for Treatment and Prognosis
NCT00533130
Short Term Outcome of Pediatric Fracture of Neck Femur Fixation by Plate and Screws
NCT05878496
Femur Fracture: Functional Bracing vs. Hip Spica Cast
NCT03948139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Despite these recommendations and the general acceptance of non-operative treatment for younger children , a survey of clinical practice in Germany revealed that 50% of children under the age of 3 years are treated with ESIN, because some surgeons believe that patients seem less comfortable when treated with traction or spica casting and might experience a higher rate of loss of reduction. Consequently, the use of ESIN for fractures in preschool children has become more prevalent in the last years.
Similarly, there is wide variation in the preferred management of femoral shaft fractures in older children, with little evidence about the comparative effectiveness of different treatments for pediatric femur fractures. There is an imperative to collect prospective data to generate higher quality evidence.
The purpose of this proposed registry is to collect the clinical outcomes (fracture healing \& patient reported outcomes and complications) of the treatment of isolated femur shaft fractures in children up to skeletal maturity. Additionally, health economic aspects will be evaluated to give possible recommendations from a health economic perspective.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Femoral shaft fracture
Patients (children up to 16 years old) diagnosis of isolated closed femur shaft fracture (3.2-D) and open distal physis. Treatment strategies will follow standard of care (routine) procedures, either conservative (non-surgical) treatment or surgical treatment.
Conservative (non-surgical) treatment
Spica cast Traction Traction and spica cast
Surgical treatment
Elastic Stable Intramedullary Nailing (ESIN) Conventional locking intramedullary nail Plating External fixation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conservative (non-surgical) treatment
Spica cast Traction Traction and spica cast
Surgical treatment
Elastic Stable Intramedullary Nailing (ESIN) Conventional locking intramedullary nail Plating External fixation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Open distal physis of the femur
* Diagnosis of isolated closed femur shaft fracture (3.2-D)
* Willingness and ability of the patient/parents/legally responsible care giver to participate in the clinical investigation including imaging and FU procedures as standard of care in each clinic
* Willingness and ability of the parent(s) to support the patient in his/her study participation
* Ability of parents to understand the content of the patient information / ICF and participation in the clinical investigation
* Signed ICF by patient and/or parent(s) according to local policies and regulations
Exclusion Criteria
* Closed distal physis of the femur
* Pathologic fractures and fractures in patients with metabolic bone disease, osteogenesis imperfecta, neuromuscular disorder, endocrinologic disease or other conditions influencing the bony structure
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AO Innovation Translation Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter P. Schmittenbecher, Prof.
Role: PRINCIPAL_INVESTIGATOR
Kinderchirurgische Klinik, Klinikum Karlsruhe
Unni G. Narayanan, Prof.
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children, Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Medical University Hospital of Graz
Graz, , Austria
BC Children's Hospital
Vancouver, British Columbia, Canada
IWK Health Centre
Halifax, New Scotland, Canada
Children's Hospital of Eastern Ontario (CHEO)
Ottawa, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Universitätsklinik Dresden
Dresden, , Germany
University Medicine Göttingen (UMG)
Göttingen, , Germany
Altonaer Kinderkrankenhaus GmbH
Hamburg, , Germany
Städt. Klinikum Karlsruhe
Karlsruhe, , Germany
University of Leipzig
Leipzig, , Germany
University Hospital Tübingen
Tübingen, , Germany
Inselspital
Bern, , Switzerland
Childrens Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PedFemFx
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.